References
1. To, C.T., Tsao, M.S., The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review). Oncol Rep 5(5): 1013-24 (1998). 2. Camp, R.L., Rimm, E.B., Rimm, D.L., Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 86(11): 2259-65 (1999). 3. Nakajima, M., et al., The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 85(9): 1894-902 (1999). 4. Wagatsuma, S., et al., Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 82(3): 520-30 (1998). 5. Elias, J.M., et al., Sensitivity and Detection Efficiency of the PAP, ABC and LAB Methods. Am. J. Clin. Pathol. 92: 62-67 (1989). 6. Shi, Z.R., Itzkowitz, S.H., Kim, Y.S., A Comparison of Three Immunoperoxidase Techniques for Antigen Detection in Colorectal Carcinoma Tissues. J. Histochemistry and Cytochemistry 36(3): 317-322 (1988). 7. Kiernan, J.A., Histological and Histochemical Methods: Theory and Practice. New York: Pergamon Press (1981). 8. Sheehan, D.C., Hrapchak, B.B., Theory and Practice of Histotechnology. St. Louis: C.V. Mosby Co. (1980). 9. Taylor, Cote, Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist. 2nd Ed. W.B. Saunders Co. Philadelphia, (1994). 10. Elias, J.M., et al., Special Report: Quality Control in immunohistochemistry. Am. J. Clin. Path. 92: 836 (1989). 11. O'Leary, T.J., et al., Quality assurance for immunocytochemistry: Proposed guideline MM4-P. National Committee for Clinical Laboratory Standards (NCCLS). Wayne, PA. 1-46. (1997). 12. College of American Pathologists (CAP) Certification Program for Immunohistochemistry. Northfield, IL. Http://www.cap.org (800) 323-4040. 13. Clinical Laboratory Improvement Amendments of 1988: Final Rule, 57 FR 7163 (February 28, 1992. ) 14. Koretzik, K., et al., Metachromasia of AEC and its precision in immunoperoxidase techniques. Histochemistry. 86: 471-478. (1987).